Track Herborium Group, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Herborium Group, Inc. HBRM · Stock Open Herborium Group, Inc. in new tab

0.000100 USD
P/B
0.00
Beta
78.00
Loading chart...
Key Metrics
Book Value-2.03
Price to Book0.00
Growth
Revenue Growth0.23%

DCF valuation

Model fair value for Herborium Group, Inc. (HBRM)
Result
Sign in to run the valuation for HBRM.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Herborium Group, Inc. Logo Herborium Group, Inc. Analysis (HBRM)

United States Health Care Official Website Stock

Is Herborium Group, Inc. a good investment? Herborium Group, Inc. (HBRM) is currently trading at 0.000100 USD.

Investor FAQ

Does Herborium Group, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Herborium Group, Inc.?

Herborium Group, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals. The company offers dermatology products, which include AcnEase, an herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars. The company sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. The company is headquartered in Sugar Land, Texas.

Exchange Ticker
PNK (United States) HBRM
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Jan. 27, 2014 Needs review
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion